Titan Medical Inc.
Titan Medical Inc. TMDIF Peers
See (TMDIF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMDIF | $0.82 | +2173.99% | 13.91M | -0.65 | -$1.25 | N/A |
| SEMHF | $55.30 | +0.04% | 62.02B | 26.59 | $2.08 | +2.03% |
| SMMNY | $27.46 | -0.76% | 61.60B | 26.40 | $1.04 | +1.22% |
| RYLPF | $24.21 | -4.86% | 22.40B | 83.49 | $0.29 | +3.89% |
| SONVF | $338.73 | -0.65% | 20.19B | 31.33 | $10.81 | +1.72% |
| SONVY | $66.85 | -1.41% | 19.92B | 30.95 | $2.16 | +1.42% |
| SNNUF | $14.21 | -0.63% | 12.43B | 30.23 | $0.47 | +2.64% |
| CHEOF | $175.40 | +3.18% | 11.44B | 48.59 | $3.61 | +1.58% |
| CHEOY | $86.72 | -2.19% | 11.34B | 47.91 | $1.81 | +1.61% |
| WILYY | $20.20 | +4.94% | 8.94B | 20.20 | $1.00 | N/A |
Stock Comparison
TMDIF vs SEMHF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SEMHF has a market cap of 62.02B. Regarding current trading prices, TMDIF is priced at $0.82, while SEMHF trades at $55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SEMHF's P/E ratio is 26.59. In terms of profitability, TMDIF's ROE is -1.06%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, TMDIF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SMMNY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SMMNY has a market cap of 61.60B. Regarding current trading prices, TMDIF is priced at $0.82, while SMMNY trades at $27.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SMMNY's P/E ratio is 26.40. In terms of profitability, TMDIF's ROE is -1.06%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, TMDIF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs RYLPF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, RYLPF has a market cap of 22.40B. Regarding current trading prices, TMDIF is priced at $0.82, while RYLPF trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas RYLPF's P/E ratio is 83.49. In terms of profitability, TMDIF's ROE is -1.06%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, TMDIF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SONVF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SONVF has a market cap of 20.19B. Regarding current trading prices, TMDIF is priced at $0.82, while SONVF trades at $338.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SONVF's P/E ratio is 31.33. In terms of profitability, TMDIF's ROE is -1.06%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, TMDIF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SONVY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SONVY has a market cap of 19.92B. Regarding current trading prices, TMDIF is priced at $0.82, while SONVY trades at $66.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SONVY's P/E ratio is 30.95. In terms of profitability, TMDIF's ROE is -1.06%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, TMDIF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SNNUF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SNNUF has a market cap of 12.43B. Regarding current trading prices, TMDIF is priced at $0.82, while SNNUF trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SNNUF's P/E ratio is 30.23. In terms of profitability, TMDIF's ROE is -1.06%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, TMDIF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CHEOF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CHEOF has a market cap of 11.44B. Regarding current trading prices, TMDIF is priced at $0.82, while CHEOF trades at $175.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CHEOF's P/E ratio is 48.59. In terms of profitability, TMDIF's ROE is -1.06%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, TMDIF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CHEOY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CHEOY has a market cap of 11.34B. Regarding current trading prices, TMDIF is priced at $0.82, while CHEOY trades at $86.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CHEOY's P/E ratio is 47.91. In terms of profitability, TMDIF's ROE is -1.06%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, TMDIF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs WILYY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, WILYY has a market cap of 8.94B. Regarding current trading prices, TMDIF is priced at $0.82, while WILYY trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas WILYY's P/E ratio is 20.20. In terms of profitability, TMDIF's ROE is -1.06%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, TMDIF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs WILLF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, WILLF has a market cap of 7.86B. Regarding current trading prices, TMDIF is priced at $0.82, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas WILLF's P/E ratio is 19.11. In terms of profitability, TMDIF's ROE is -1.06%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, TMDIF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs GNGBY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, GNGBY has a market cap of 5.51B. Regarding current trading prices, TMDIF is priced at $0.82, while GNGBY trades at $20.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas GNGBY's P/E ratio is 35.96. In terms of profitability, TMDIF's ROE is -1.06%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, TMDIF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs GNGBF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, TMDIF is priced at $0.82, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, TMDIF's ROE is -1.06%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, TMDIF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs AMBBY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, AMBBY has a market cap of 4.18B. Regarding current trading prices, TMDIF is priced at $0.82, while AMBBY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas AMBBY's P/E ratio is 75.05. In terms of profitability, TMDIF's ROE is -1.06%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, TMDIF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs NHNKY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, NHNKY has a market cap of 4.06B. Regarding current trading prices, TMDIF is priced at $0.82, while NHNKY trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas NHNKY's P/E ratio is 21.24. In terms of profitability, TMDIF's ROE is -1.06%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, TMDIF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs AMBFF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, AMBFF has a market cap of 4.02B. Regarding current trading prices, TMDIF is priced at $0.82, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, TMDIF's ROE is -1.06%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, TMDIF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs NHNKF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, TMDIF is priced at $0.82, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, TMDIF's ROE is -1.06%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, TMDIF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs VTRLY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, TMDIF is priced at $0.82, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, TMDIF's ROE is -1.06%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, TMDIF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs STSEY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, TMDIF is priced at $0.82, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas STSEY's P/E ratio is 39.41. In terms of profitability, TMDIF's ROE is -1.06%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, TMDIF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs GNNDY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, GNNDY has a market cap of 2.02B. Regarding current trading prices, TMDIF is priced at $0.82, while GNNDY trades at $41.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas GNNDY's P/E ratio is 16.74. In terms of profitability, TMDIF's ROE is -1.06%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, TMDIF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs GGNDF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, TMDIF is priced at $0.82, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas GGNDF's P/E ratio is 15.66. In terms of profitability, TMDIF's ROE is -1.06%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, TMDIF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs OSSFF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, TMDIF is priced at $0.82, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, TMDIF's ROE is -1.06%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, TMDIF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs DWRKF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, TMDIF is priced at $0.82, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, TMDIF's ROE is -1.06%, compared to DWRKF's ROE of N/A. Regarding short-term risk, TMDIF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs MCRPF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, TMDIF is priced at $0.82, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, TMDIF's ROE is -1.06%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, TMDIF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SSII Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SSII has a market cap of 1.73B. Regarding current trading prices, TMDIF is priced at $0.82, while SSII trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SSII's P/E ratio is -111.37. In terms of profitability, TMDIF's ROE is -1.06%, compared to SSII's ROE of -1.33%. Regarding short-term risk, TMDIF is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs OSSUY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, TMDIF is priced at $0.82, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, TMDIF's ROE is -1.06%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, TMDIF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs MEDGF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, TMDIF is priced at $0.82, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, TMDIF's ROE is -1.06%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, TMDIF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs DRWKF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, DRWKF has a market cap of 1.23B. Regarding current trading prices, TMDIF is priced at $0.82, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas DRWKF's P/E ratio is 9.10. In terms of profitability, TMDIF's ROE is -1.06%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, TMDIF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs DGWPF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, DGWPF has a market cap of 1.19B. Regarding current trading prices, TMDIF is priced at $0.82, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas DGWPF's P/E ratio is 7.71. In terms of profitability, TMDIF's ROE is -1.06%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, TMDIF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs XVIPF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, TMDIF is priced at $0.82, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, TMDIF's ROE is -1.06%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, TMDIF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs LFTSF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, TMDIF is priced at $0.82, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, TMDIF's ROE is -1.06%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, TMDIF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs ELEAF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, TMDIF is priced at $0.82, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas ELEAF's P/E ratio is 12.22. In terms of profitability, TMDIF's ROE is -1.06%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, TMDIF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs MDRSF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, TMDIF is priced at $0.82, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, TMDIF's ROE is -1.06%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, TMDIF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CALZF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CALZF has a market cap of 615.54M. Regarding current trading prices, TMDIF is priced at $0.82, while CALZF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CALZF's P/E ratio is 89.10. In terms of profitability, TMDIF's ROE is -1.06%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, TMDIF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs AVMR Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, TMDIF is priced at $0.82, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas AVMR's P/E ratio is -18.34. In terms of profitability, TMDIF's ROE is -1.06%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, TMDIF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CLVSF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, TMDIF is priced at $0.82, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, TMDIF's ROE is -1.06%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, TMDIF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs IOBCF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, IOBCF has a market cap of 388.16M. Regarding current trading prices, TMDIF is priced at $0.82, while IOBCF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas IOBCF's P/E ratio is 37.86. In terms of profitability, TMDIF's ROE is -1.06%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, TMDIF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs HYBT Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, TMDIF is priced at $0.82, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas HYBT's P/E ratio is N/A. In terms of profitability, TMDIF's ROE is -1.06%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, TMDIF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs EAPIF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, TMDIF is priced at $0.82, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas EAPIF's P/E ratio is -1.98. In terms of profitability, TMDIF's ROE is -1.06%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, TMDIF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SNWV Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SNWV has a market cap of 266.94M. Regarding current trading prices, TMDIF is priced at $0.82, while SNWV trades at $31.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SNWV's P/E ratio is -5.01. In terms of profitability, TMDIF's ROE is -1.06%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, TMDIF is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CSSPF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, TMDIF is priced at $0.82, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, TMDIF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CYBQY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CYBQY has a market cap of 254.83M. Regarding current trading prices, TMDIF is priced at $0.82, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CYBQY's P/E ratio is -61.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, TMDIF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CLLKF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CLLKF has a market cap of 253.16M. Regarding current trading prices, TMDIF is priced at $0.82, while CLLKF trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CLLKF's P/E ratio is -8.14. In terms of profitability, TMDIF's ROE is -1.06%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, TMDIF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs HTLZF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, TMDIF is priced at $0.82, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, TMDIF's ROE is -1.06%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, TMDIF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs BCCOY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, BCCOY has a market cap of 221.04M. Regarding current trading prices, TMDIF is priced at $0.82, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, TMDIF's ROE is -1.06%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, TMDIF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs IMPZY Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, TMDIF is priced at $0.82, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, TMDIF's ROE is -1.06%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, TMDIF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs AVHHL Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, AVHHL has a market cap of 176.38M. Regarding current trading prices, TMDIF is priced at $0.82, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, TMDIF's ROE is -1.06%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, TMDIF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CYBQF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, TMDIF is priced at $0.82, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, TMDIF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs BRNHF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, TMDIF is priced at $0.82, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, TMDIF's ROE is -1.06%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, TMDIF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs EKDHF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, TMDIF is priced at $0.82, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, TMDIF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs JMDMF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, TMDIF is priced at $0.82, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, TMDIF's ROE is -1.06%, compared to JMDMF's ROE of N/A. Regarding short-term risk, TMDIF is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs PXMBF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, PXMBF has a market cap of 142.82M. Regarding current trading prices, TMDIF is priced at $0.82, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, TMDIF's ROE is -1.06%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, TMDIF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs BRSYF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, TMDIF is priced at $0.82, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, TMDIF's ROE is -1.06%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, TMDIF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs AMEUF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, TMDIF is priced at $0.82, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, TMDIF's ROE is -1.06%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, TMDIF is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs VMTHF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, TMDIF is priced at $0.82, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, TMDIF's ROE is -1.06%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, TMDIF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs FDMDF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, TMDIF is priced at $0.82, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, TMDIF's ROE is -1.06%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, TMDIF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs RSHUF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, TMDIF is priced at $0.82, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, TMDIF's ROE is -1.06%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, TMDIF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CKMTF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, TMDIF is priced at $0.82, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, TMDIF's ROE is -1.06%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, TMDIF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SOMNF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, TMDIF is priced at $0.82, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, TMDIF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs DMTRF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, TMDIF is priced at $0.82, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, TMDIF's ROE is -1.06%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, TMDIF is more volatile compared to DMTRF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs SNZZF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, TMDIF is priced at $0.82, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, TMDIF's ROE is -1.06%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, TMDIF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs RDGL Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, RDGL has a market cap of 50.79M. Regarding current trading prices, TMDIF is priced at $0.82, while RDGL trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas RDGL's P/E ratio is -11.20. In terms of profitability, TMDIF's ROE is -1.06%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, TMDIF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs BLOZF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, BLOZF has a market cap of 49.41M. Regarding current trading prices, TMDIF is priced at $0.82, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas BLOZF's P/E ratio is -21.45. In terms of profitability, TMDIF's ROE is -1.06%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, TMDIF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs IPDQF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, IPDQF has a market cap of 40.55M. Regarding current trading prices, TMDIF is priced at $0.82, while IPDQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas IPDQF's P/E ratio is -2.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, TMDIF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs NVYTF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, TMDIF is priced at $0.82, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas NVYTF's P/E ratio is -0.74. In terms of profitability, TMDIF's ROE is -1.06%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, TMDIF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs TLTFF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, TLTFF has a market cap of 30.35M. Regarding current trading prices, TMDIF is priced at $0.82, while TLTFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas TLTFF's P/E ratio is -12.25. In terms of profitability, TMDIF's ROE is -1.06%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, TMDIF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs ELXMF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, TMDIF is priced at $0.82, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, TMDIF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs PYNKF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, PYNKF has a market cap of 27.75M. Regarding current trading prices, TMDIF is priced at $0.82, while PYNKF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas PYNKF's P/E ratio is -1.65. In terms of profitability, TMDIF's ROE is -1.06%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, TMDIF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs KBBTF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, TMDIF is priced at $0.82, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, TMDIF's ROE is -1.06%, compared to KBBTF's ROE of N/A. Regarding short-term risk, TMDIF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs EMITF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, TMDIF is priced at $0.82, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas EMITF's P/E ratio is -15.38. In terms of profitability, TMDIF's ROE is -1.06%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, TMDIF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs POSC Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, POSC has a market cap of 22.13M. Regarding current trading prices, TMDIF is priced at $0.82, while POSC trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas POSC's P/E ratio is 0.39. In terms of profitability, TMDIF's ROE is -1.06%, compared to POSC's ROE of +9.25%. Regarding short-term risk, TMDIF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs ASAPF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, ASAPF has a market cap of 16.91M. Regarding current trading prices, TMDIF is priced at $0.82, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas ASAPF's P/E ratio is -21.90. In terms of profitability, TMDIF's ROE is -1.06%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, TMDIF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs MDXHF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, MDXHF has a market cap of 15.40M. Regarding current trading prices, TMDIF is priced at $0.82, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, TMDIF's ROE is -1.06%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, TMDIF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs VPTDF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, VPTDF has a market cap of 14.46M. Regarding current trading prices, TMDIF is priced at $0.82, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas VPTDF's P/E ratio is -4.43. In terms of profitability, TMDIF's ROE is -1.06%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, TMDIF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs DIZTF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, TMDIF is priced at $0.82, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, TMDIF's ROE is -1.06%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, TMDIF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs PLLWF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, TMDIF is priced at $0.82, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, TMDIF's ROE is -1.06%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, TMDIF is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs RMSL Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, RMSL has a market cap of 12.74M. Regarding current trading prices, TMDIF is priced at $0.82, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas RMSL's P/E ratio is 0.83. In terms of profitability, TMDIF's ROE is -1.06%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, TMDIF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs ATBPF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, TMDIF is priced at $0.82, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, TMDIF's ROE is -1.06%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, TMDIF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs LXXGF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, TMDIF is priced at $0.82, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, TMDIF's ROE is -1.06%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, TMDIF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs GTHP Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, GTHP has a market cap of 9.86M. Regarding current trading prices, TMDIF is priced at $0.82, while GTHP trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas GTHP's P/E ratio is -2.50. In terms of profitability, TMDIF's ROE is -1.06%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, TMDIF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs IRME Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, IRME has a market cap of 8.64M. Regarding current trading prices, TMDIF is priced at $0.82, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas IRME's P/E ratio is -4.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to IRME's ROE of +11.77%. Regarding short-term risk, TMDIF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs MKEAF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, MKEAF has a market cap of 6.43M. Regarding current trading prices, TMDIF is priced at $0.82, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, TMDIF's ROE is -1.06%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, TMDIF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs DTXMF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, TMDIF is priced at $0.82, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, TMDIF's ROE is -1.06%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, TMDIF is more volatile compared to DTXMF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs TBRIF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, TBRIF has a market cap of 5.45M. Regarding current trading prices, TMDIF is priced at $0.82, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas TBRIF's P/E ratio is -1.20. In terms of profitability, TMDIF's ROE is -1.06%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, TMDIF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs QLIS Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, TMDIF is priced at $0.82, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas QLIS's P/E ratio is 2.22. In terms of profitability, TMDIF's ROE is -1.06%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, TMDIF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs RHNMF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, TMDIF is priced at $0.82, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, TMDIF's ROE is -1.06%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, TMDIF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs MICR Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, TMDIF is priced at $0.82, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas MICR's P/E ratio is -3.47. In terms of profitability, TMDIF's ROE is -1.06%, compared to MICR's ROE of -0.25%. Regarding short-term risk, TMDIF is more volatile compared to MICR. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs FZMD Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, TMDIF is priced at $0.82, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas FZMD's P/E ratio is 1.20. In terms of profitability, TMDIF's ROE is -1.06%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, TMDIF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs NUMD Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, NUMD has a market cap of 4.34M. Regarding current trading prices, TMDIF is priced at $0.82, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas NUMD's P/E ratio is 5.20. In terms of profitability, TMDIF's ROE is -1.06%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, TMDIF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs LBLTF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, TMDIF is priced at $0.82, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, TMDIF's ROE is -1.06%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, TMDIF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs ADMT Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, ADMT has a market cap of 4.06M. Regarding current trading prices, TMDIF is priced at $0.82, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas ADMT's P/E ratio is -6.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, TMDIF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs VYCO Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, VYCO has a market cap of 4.00M. Regarding current trading prices, TMDIF is priced at $0.82, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas VYCO's P/E ratio is -12.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, TMDIF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs ALRTF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, ALRTF has a market cap of 3.81M. Regarding current trading prices, TMDIF is priced at $0.82, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas ALRTF's P/E ratio is -0.20. In terms of profitability, TMDIF's ROE is -1.06%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, TMDIF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs BIEL Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, TMDIF is priced at $0.82, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas BIEL's P/E ratio is N/A. In terms of profitability, TMDIF's ROE is -1.06%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, TMDIF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs VANIW Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, TMDIF is priced at $0.82, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas VANIW's P/E ratio is N/A. In terms of profitability, TMDIF's ROE is -1.06%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, TMDIF is more volatile compared to VANIW. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs ESMC Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, ESMC has a market cap of 3.09M. Regarding current trading prices, TMDIF is priced at $0.82, while ESMC trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas ESMC's P/E ratio is 8.34. In terms of profitability, TMDIF's ROE is -1.06%, compared to ESMC's ROE of +0.47%. Regarding short-term risk, TMDIF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs PMEDF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, PMEDF has a market cap of 3.01M. Regarding current trading prices, TMDIF is priced at $0.82, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas PMEDF's P/E ratio is -2.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, TMDIF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs USAQ Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, USAQ has a market cap of 2.99M. Regarding current trading prices, TMDIF is priced at $0.82, while USAQ trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas USAQ's P/E ratio is -6.62. In terms of profitability, TMDIF's ROE is -1.06%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, TMDIF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs KLYG Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, KLYG has a market cap of 2.02M. Regarding current trading prices, TMDIF is priced at $0.82, while KLYG trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas KLYG's P/E ratio is -16.00. In terms of profitability, TMDIF's ROE is -1.06%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, TMDIF is more volatile compared to KLYG. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.
TMDIF vs CRRVF Comparison
TMDIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMDIF stands at 13.91M. In comparison, CRRVF has a market cap of 1.54M. Regarding current trading prices, TMDIF is priced at $0.82, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMDIF currently has a P/E ratio of -0.65, whereas CRRVF's P/E ratio is N/A. In terms of profitability, TMDIF's ROE is -1.06%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, TMDIF is more volatile compared to CRRVF. This indicates potentially higher risk in terms of short-term price fluctuations for TMDIF.